As a result, the in vivo tumorigenic potential (i.e., sphere-forming, anchorage-independent growth, cancer cells migratory, and drug resistance) were significantly reduced in the NANOG, and NANOGP8 knockout cell lines (KHOS and MNNG/HOS). This evidence concerns the gene NANOG and cancer.